Sumitomo Pharma Co., Ltd. (TYO:4506)

Sumitomo Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	420,333	289,624	158,122	321,807	479,930	765,586
Market Cap Growth	83.17%	83.17%	-50.86%	-32.95%	-37.31%	37.35%
Enterprise Value	702,639	578,654	533,549	346,137	606,587	926,427
Last Close Price	1058.00	729.00	398.00	810.00	1180.81	1850.26
PE Ratio	17.79	12.26	-	-	8.51	13.62
Forward PE	8.94	19.16	-	-	11.10	19.40
PS Ratio	1.05	0.73	0.50	0.58	0.86	1.48
PB Ratio	2.48	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	52.53	36.19	-	92.74	20.09	5.91
P/OCF Ratio	25.47	17.55	-	26.96	15.36	5.65
PEG Ratio	0.88	1.27	1.27	1.27	1.27	1.27
EV/Sales Ratio	1.76	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	18.65	15.00	-	-	6.17	12.04
EV/EBIT Ratio	57.98	44.43	-	-	10.12	17.06
EV/FCF Ratio	87.81	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	1.80	1.80	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	7.92	7.92	-	-	2.89	3.78
Debt / FCF Ratio	38.17	38.17	-	99.82	11.91	2.24
Asset Turnover	0.48	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.46	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.42	0.42	0.25	0.65	1.27	1.19
Current Ratio	1.05	1.05	0.52	1.03	1.79	1.65
Return on Equity (ROE)	14.52%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	0.99%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Capital (ROIC)	1.55%	1.55%	-33.20%	-9.23%	3.95%	3.60%
Return on Capital Employed (ROCE)	2.60%	2.60%	-	-	5.80%	5.30%
Earnings Yield	5.62%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	1.90%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.59%	2.37%	1.51%
Payout Ratio	0.01%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.59%	2.37%	1.51%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.